Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study

• Main Authors: Valentina Cossiga (Author), Marco Sanduzzi-Zamparelli (Author), Victor Sapena (Author), Maria Guarino (Author), Marcello Dallio (Author), Emanuele Torrisi (Author), Luca Pignata (Author), Alessandro Federico (Author), Federico Salomone (Author), Filomena Morisco (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction and Aims: HCV eradication by direct-acting antivirals (DAAs) improves liver outcomes and reduces overall liver mortality. However, patients with advanced chronic liver disease (ACLD) may experience a progression of liver disease despite viral clearance. Silybin has shown hepatoprotectiv...